Results 111 to 120 of about 13,171 (198)

Hvem adopterer ABC, hvem gjør det ikke, og hvorfor?

, 2009
Litteraturen hevder at aktivitetsbasert kalkulasjon er bedre egnet for bedrifter med enkelte spesielle egenskaper, eksempelvis høye indirekte kostnader. Gjennom denne utredningen utforskes et eventuelt samsvar mellom teori og praksis. Variablene som er valgt er basert på litteraturen, og resultatene indikerer at adopsjon av ABC ikke fullt ut blir ...
openaire   +1 more source

Advances in Immune Checkpoint Inhibitors for Cancer Treatment. [PDF]

Cancers (Basel)
Chen K, Zhu F, Li X, Yoshimura T.
europepmc   +1 more source

Special Issue "State-of-the-Art Cancer Immunotherapies-2nd Edition". [PDF]

Int J Mol Sci
Nagase H, Kato T, Yoshimoto T.
europepmc   +1 more source

TNF Pathway-Mediated Tolerogenic T-Cell Trajectory Driven by Allergen Immunotherapy. [PDF]

Allergy
Charles HS, Gabr AA, Wang SH, Zissler UM, Heine S, Heldner A, Kotz S, Pechtold L, Bonsen LSZ, Pogorelov D, Kau J, Plaschke M, Hills M, Guerth F, Oelsner M, Ohnmacht C, Alessandrini F, Blank S, Chaker AM, Schmidt-Weber CB, Jakwerth CA.   +20 more
europepmc   +1 more source

Immune cells and rheumatic heart disease: A 2-sample and Bayesian weighted Mendelian randomization study. [PDF]

Medicine (Baltimore)
Xue S, Jiang H, Liu C, Zhou Y.
europepmc   +1 more source

BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy. [PDF]

Pharmaceuticals (Basel)
Chang MC, Lee WC, Tai YJ, Chiang YC.
europepmc   +1 more source

CD4-Based Chimeric Antigen Receptor (CAR)-T Cells With Resistance to HIV-1 Infection and Enhanced Anti-HIV Efficacy: Covalent Interaction Between CD4-CAR and HIV-1 Envelope Glycoprotein. [PDF]

J Med Virol
Lou Y, He X, Li G, Sikhondze M, Ma J, Du H, Ouyang X, Dotti G, Sajadi M, Su L.   +9 more
europepmc   +1 more source

Multiplex profiling of 16 immune checkpoints identifies novel serum biomarker panels for breast cancer detection and TNBC stratification: A case-control study. [PDF]

PLoS One
Stayoussef M, Habel A, Xu W, Bessaad M, Bouaziz H, Ayadi M, Almawi WY, Larbi A, Yacoubi-Loueslati B.   +8 more
europepmc   +1 more source

Targeting TNK2/ACK1 reverses the immunosuppressive tumor microenvironment and synergizes with immunochemotherapy in pancreatic cancer. [PDF]

Nat Commun
Wu C, Liu W, Hu X, Xie Y, Li S, Liu X, Sun Z, Li X, Yu X, Yuan Y, Zou Y, An R, Chen Y, Wang H, Feng Y, Gao S, Wang H, Wang Y, Wang N, Yang C, Yu J, Sun P, Huang C, Chang A, Hao J.   +24 more
europepmc   +1 more source

Causal role of immunophenotypes in hepatocellular carcinoma: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Ou D, Huo J.
europepmc   +1 more source